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Objective: To contribute to clarify molecular mechanisms supporting senescence and de-differentiation
of chondrocytes in chondrocyte pathologies such as osteoarthritis (OA). Speciﬁcally, we investigated
the relationship between the nuclear lamina protein Lamin B1 and the negative regulator of chondro-
genesis Slug transcription factor in osteoarthritic chondrocytes.
Methods: Lamin B1 and Slug proteins were analyzed in cartilage explants from normal subjects and OA
patients by immunohistochemical technique. Their expression was conﬁrmed on isolated chondrocytes
both at passage 0 and passage 2 (de-differentiated chondrocytes) by immunoﬂuorescence and western
blot. Subsequently, we explored the “in vivo” binding of Slug on LMNB1 promoter by chromatin
immunoprecipitation assay (ChIP).
Results: In this study we demonstrated that nuclear lamina protein Lamin B1 and anti-chondrogenic Slug
transcription factor are upregulated in cartilage and OA chondrocytes. Furthermore, we found that Slug is
“in vivo” recruited by LMNB1 gene promoter mostly when chondrocytes undergo de-differentiation or
OA degeneration.
Conclusions: We described for the ﬁrst time a potential regulatory role of Slug on the LMNB1 gene
expression in OA chondrocytes. These ﬁndings may have important implications for the study of pre-
mature senescence, and degeneration of cartilage, and may contribute to develop effective therapeutic
strategies against signals supporting cartilage damage in different subsets of patients.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Lamins (A, C, B1 and B2) are nuclear intermediate ﬁlament
proteins with multifunctional characteristics1. They support the
structural integrity of the nucleus, and play a key role in a wide
range of nuclear functions, including transcription, DNA replication
and repair, control of cell cycle and stem cell niche function, cell
proliferation and differentiation of speciﬁc lineages during devel-
opment and adult life1,2. It has been demonstrated that tissue ho-
meostasis can be disrupted by different mutations or abundanceto: R. Piva, Department of
ity of Ferrara, Via Fossato di
5.
ternational. Published by Elsevier Lvariation in lamins causing a variety of diseases, collectively termed
laminopathies, including the premature aging syndrome Hutch-
insoneGilford progeria3. In recent years, the study on the lamins
contributed to a better understanding of the phenomenon of
cellular aging, tissue degeneration and pathogenesis of age-related
diseases. Interestingly, changes of A:B lamin stoichiometry is
correlatedwith stifness, and tissues such as cartilage and bone have
a high A:B ratio4. Over-expression of lamin A or the presence of its
mutant form progerin leads to defects in chondrogenic differenti-
ation potential of mesenchymal stem cells (MSCs)5. High levels of
lamin A were found in osteoarthritic chondrocytes6, whilst lamin
B's contribution remains unexplored. Osteoarthritis (OA) is a
common degenerative joint disease characterized by cellular
senescence, loss of chondrocyte activity and degradation of artic-
ular cartilage7. Due to the complexity of these phenomena, there is
a limited understanding in OA pathogenesis. The hypothesis to betd. All rights reserved.
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inducing conditions converges on de-differentiation and acquisi-
tion of stem cell-like properties. This might occur before reentry
into the cell cycle or acquisition of the senescent phenotype. Clar-
ifying this issue may be important to devise new approaches for OA
prevention and treatment.
We recently found that Slug, an antichondrogenic transcription
factor, is a marker of chondrocyte de-differentiation8. In order to
ﬁnd new Slug target molecules and to explore the partecipation of
lamin B1 in the cartilage damage, we investigated their expression




Knee cartilage explants from normal subjects (at autopsy, n ¼ 3,
age ¼ 55 ± 3 years, sex ¼ male, Mankin score ¼ 0e3) and OA pa-
tients (from joint replacement, n ¼ 6, age ¼ 58 ± 7 years,
sex ¼male, Mankin score ¼ 8e10) were ﬁxed in a freshly prepared
9:1 mixture of B5 solution (mercuric-chloride containing ﬁxative)/
40% formaldehyde at room temperature for 2 h, dehydrated and
embedded in parafﬁn as previously described9. The slides were
then incubated using the following antibodies: b-galactosidase
(goat anti-human 1:200) from Santa Cruz Biotechnology (Santa
Cruz, CA, USA); Slug (mouse anti-human, 1:300) from Origene
(Rockville, MD, USA), Lamin A (rabbit anti-human 1:200) and
Lamin B1 (rabbit anti-human 1:200) from Abcam (Cambridge,UK)
overnight at 4C, washed and incubated with anti-goat- or goat-
anti-mouse/rabbit-biotinilated and alkaline phosphatase-
conjugated streptavidin (Kit BioGenex, San Ramon, CA, USA) at
room temperature for 30 min. Slides were developed using new
fast red as substrate and evaluated using a brightﬁeld microscope.
Safranin O staining was also performed. The study was approved by
local ethical committee at Istituto Ortopedico Rizzoli.
Cell culture, immunoﬂuorescence and gene expression analysis
Normal (n ¼ 3) and osteoarthritic chondrocytes (n ¼ 6) were
isolated from articular cartilage by sequential enzymatic digestion
as previously described10. Cells from passage 0 (p0) to passage 2
(p2) were grown on glass coverslips were ﬁxed in methanol
at 20C for 7 min, blocked in 4% BSA-PBS and incubated with
rabbit anti-human-Slug (clone H140, 1:10, Santa Cruz Biotech-
nology) and mouse anti-human Lamin B1 (clone 8D1, 1:100, Santa
Cruz Biotechnology) overnight at 4C. Coverslips were next washed
and incubated with ﬂuorescence-labeled secondary antibodies
(SigmaeAldrich Chemical Co., St. Louis, MO) for 1 h at room tem-
perature. Nuclei were counterstained with DAPI (4,6-diamino-2-
phenylindole). Slides were mounted with antifade reagent in
glycerol and observed with a Nikon E600 epiﬂuorescence micro-
scope (100magniﬁcation, 1,3 NA e numerical aperture) equipped
with a digital camera. Images were processed using Adobe Photo-
shop (Adobe Systems).
Total RNA was extracted from cells at p0 and p2, reverse tran-
scribed and PCR performed for collagen type I, collagen type II and
Sox9 as previously described10.
Western blotting
20 mg of whole cell lysates were resolved by SDS-PAGE, trans-
ferred to PVDF (Millipore, Billerica, MA, USA) and blockedwith PBS-
0.05% Tween 20/5% NFDM, then probed overnight (4C) with the
following antibodies: Slug (mouse anti-human, clone A-7, 1:1000),Actin (mouse anti-human, clone C-2, 1:5000) from Santa Cruz
Biotechnology, and Lamin B1 (rabbit anti-human 1:1500) from
Abcam. After washing, the membranes were incubated with anti-
mouse or anti-rabbit HRP conjugated antibodies (DAKO, Glostrup,
Denmark) 1:2000, and signals were detected by Supersignal West
Femto Substrate (Pierce, Rockford, IL, USA). Actin was used to
conﬁrm equal protein loading.
Chromatin immunoprecipitation assay (ChIP)
ChIP was performed using a CHIP assay kit (Upstate Biotech-
nology, Waltham, MA, USA) according to the manufacturer's in-
structions as previously described8. Chromatin samples from
normal or OA chondrocytes were immunoprecipitated with a
speciﬁc primary Slug antibody. IgG antibody was used as a negative
control (all antibodies were purchased from Santa Cruz
Biotechnology).
PCR was carried out with three primer sets (Set 1: upper: 50-
GTCACCCTCGTCTTGCATTT-30, lower: 50-GCGTTTAGAGGAACGGA-
GAA-30; Set 2: upper: 50-GTAGAGACGGGGTTTCACCA-30, lower: 50-
TGGATTACCCATCCACACAA-30; and Set 3: upper: 50-ACGGGGTTT-
CACTATGTTGG-30 lower: 50-TTGGTTGTGAGACCCTTTCC-30), span-
ning Slug binding sites in the hLMNB1 gene promoter.
Results
Loss of chondrocyte-speciﬁc properties was detected in
degenerated cartilage tissue from OA patients. As shown in
Fig. 1(A), OA cartilage showed a low level of Safranin O staining
for sulfated glicosaminoglycans, and increased senescence-
associated b-galactosidase and Lamin A immunostaining. This
conﬁrmed that a combination of phenomena including deterio-
ration of tissue function and senescence occurs in OA cartilage. In
search for new mediators of cartilage damage, we next analyzed
tissue sections for the presence of another key player in cellular
senescence, Lamin B1, and an anti-chondrogenic molecule, Slug
transcription factor. Interestingly, the expression of Lamin B1 was
increased in OA cartilage compared to normal samples and Slug
colocalized with Lamin B1 [Fig. 1(B)]. Noteworthy, in normal
cartilage few Slug-positive cells were present, both in the su-
perﬁcial/intermediate and deep area of the tissue. Conversely, a
higher number of Slug-positive cells, located in all cartilage
layers, were detected in OA cartilage. As senescence of chon-
drocytes is inherent to the OA process7, we state that Slug, in
addition to being a marker of cell de-differentiation8, can also be
associated to senescence.
We conﬁrmed this hypothesis in isolated normal and OA
chondrocytes that were de-differentiated through prolonged
passages in monolayer culture. In accordance with literature
data10,11, we conﬁrmed the loss of the cartilagineous phenotype
associated with de-differentiation process by demonstrating a
decrease in the expression of typical chondrogenic markers,
including collagen type II and Sox9, and an increase of collagen
type I [Fig. 2(A)]. As previously demonstrated8, Slug protein
gradually increased to very high levels during de-differentiation
process of normal chondrocytes. This phenomenon was observed
here, for the ﬁrst time, also in OA chondrocytes, as shown by the
immunoblot analysis reported in Fig. 2(A). The same analysis
revealed the presence of Lamin B1 in p0 chondrocytes and de-
differentiated p2 chondrocytes from healthy subjects and OA pa-
tients. Higher Slug levels were determined in OA samples
compared with controls. This was conﬁrmed by immunoﬂuores-
cence analysis showing that Lamin B1 localized at the nuclear
periphery, while Slug was mostly recruited in the nuclear interior
[Fig. 2(B)].
Fig. 1. (A) Safranin O staining of the superﬁcial/intermediate and deep zone of representative normal (N) and OA cartilage showing the composition of the cartilages analyzed.
Immunohistochemical analysis of b-galactosidase, Lamin A on serial sections of cartilage from normal and OA cartilage. Bar ¼ 100 mm, Inset bar ¼ 10 mm. (B) Immunohistochemical
analysis of Lamin B1 and Slug on serial sections of cartilage from normal and OA cartilage. Bar ¼ 100 mm, Inset bar ¼ 10 mm. Negative Control, Bar ¼ 100 mm.
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tween Slug and Lamin B1, investigating a possible role of Slug as
regulator of Lamin B1 expression during chondrocyte de-
differentiation process. The possibility that Lamin B1 is a direct
transcriptional target of Slug was examined by ChIP assay. By using
the Transcription Element Search Software (TESS) for transcription
factor search and MatInspector 7.4, we identiﬁed seven potential
Slug binding sites (E-boxes, 50-CANNTG/CANNTG-30) in the LMNB1
gene 50 regulatory region, six upstream and one downstream of the
transcription start site. We focused on three chromatin subregions
of LMNB1 promoter for “in vivo” E-box occupancy analysis. We
observed Slug binding to Regions 1 and 3 in p2 OA chondrocytes,
whereas Slug was mostly recruited at Region 1 and 2 in p0 normal
chondrocytes [Fig. 2(C)]. Concomitant binding of acetylated histone
H3 (Ac-H3) conﬁrmed the active transcription of the locus (data not
shown).
Discussion
An effective strategy to prevent cartilage loss or treat cartilage
diseases is still lacking. Therefore, the search for potential molec-
ular targets that are involved in the mechanisms of pathogenesis
represents an important challenge. In this study, we described, for
the ﬁrst time, the upregulation of Slug and lamin B1 both in OA
cartilage explants and in vitro de-differentiated chondrocytes,
suggesting the implications of these molecules in two critical
phenomena involved in onset of OA, the loss of cell differentiation
and cellular senescence. We previously demonstrated that the in-
hibition of Slug, a transcriptional repressor of cartilage formation12,
is effective in inducing chondrogenesis of mesenchymal stem cells8.
Our data evidence that Slug is involved in chondrocyte senescence,possibly due to its in vivo recruitment on the promoter of LMNB1
gene. However, further studies will be needed to dissect the way
Slug can accomplish its task. Our results suggest that Slug might
drive the loss of chondrocytic phenotype through regulation of
Lamin B1 expression and lead us to speculate that Slug inhibition in
culture-expanded chondrocytes could prevent the de-
differentiation process. Contrasting roles of Lamin B1 in cellular
senescence have been described13. Reduced levels of Lamin B1 have
been observed in HGPS patient-derived ﬁbroblasts and senescent
normal ﬁbroblasts in vitro13. In one report, Lamin B1 silencing led to
apoptosis in HeLa cells14, whereas recent work suggested that in-
hibition of Lamin B1 causes senescence in WI-38 cells15.
Conversely, Lamin B1 overexpression appeared to enhance prolif-
eration and delay the onset of senescence, whereas a second study
showed that elevated levels of Lamin B1 triggered senescence13.
Our data demonstrate a marked increase of Lamin B1 in OA chon-
drocytes, in favor of the hypothesis of its association with tissue
degeneration and senescence.
Tissue degeneration and senescence involve a plethora of me-
diators so it is difﬁcult to establish a hierarchy of events. Therefore,
the key question is whether Slug and Lamin B1 are upstream or
downstream the OA pathogenetic process. However, the proof of
the in vivo molecular relationship between these two proteins
could help to identify potential mechanisms by which catabolic
changes in the articular cartilage lead to the onset of OA and to
devise new approaches for the prevention and treatment of OA.
Moreover, the evidences here described may help to improve cell-
based therapies that use chondrocytes, helping to solve the prob-
lems of cellular senescence and de-differentiation that occur during
in vitro expansion that represent one of the major practical barriers
to clinical application.
Fig. 2. (A) Collagen type II, SOX9 and Collagen type I expression levels were determined by qRT-PCR in p0 chondrocytes and p2 de-differentiated chondrocytes from healthy
subjects (N) and OA patients. Real time PCR was run in a LightCycler Instrument (Roche Molecular Biochemicals, Mannheim, Germany) using the SYBR Premix Ex Taq (TaKaRa
Biomedicals, Tokyo, Japan). For each target gene, mRNA levels were calculated, normalized to RPS9 according to the formula 2DCt and expressed as a percentage of the reference
gene. Statistical analysis was performed comparing p0 to p2 chondrocytes, using non parametric Wilcoxon matched pair test. Signiﬁcant differences *P < 0.05. Slug and Lamin B1
expression levels were determined by Western Blotting in p0 chondrocytes and de-differentiated p2 chondrocytes from healthy subjects (N) and OA patients (OA). 20 mg of each
samples were assayed on SDS-PAGE and proteins were visualized by ECL method (PIERCE). Actin was used as loading control. (B) Representative immunoﬂuorescence analysis
performed on p0 and de-differentiated p2 chondrocytes from healthy subjects (N) and OA patients (OA) using anti-Lamin B1 (red) and Slug (green) antibodies. Nuclei were
counterstained with DAPI. Merge contains the combined image of Slug and Lamin B1 immunostaining and DAPI staining. Determinations were done in triplicate in three inde-
pendent cell cultures. Bar ¼ 10 mm. (C) Schematic representation of the human LMNB1 promoter region; putative Slug binding sites are indicated with grey ovals. ChIP assay of
“in vivo” Slug binding to the Lamin B1 proximal promoter was performed. DNA templates were obtained from p0 chondrocytes and de-differentiated p2 chondrocytes from two
healthy subjects (N) and two OA patients (OA). Immunoprecipitation was performed using an anti-Slug antibody or preimmune rabbit IgG. DNA samples of ChIP reactions (Slug, IgG)
and Input DNA, collected before precipitation, were used in PCRs with different primer pairs and amplicons are reported: region 1 ¼ 174 bp, region 2 ¼ 189 bp, region 3 ¼ 178 bp.
Each PCR reaction was performed with 5 ml of the bound DNA fraction or 2 ml of the Input. PCR fragments were analyzed on 1.5% agarose gel.
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